All News
![](https://pbs.twimg.com/media/GTHepSjWsAAe9PH.jpg)
JAK Inhibitors Reduce Macular Degeneration
Insurance claims data showed that patients with autoimmune disorders who took Janus kinase (JAK) inhibitors had lower rates of age-related macular degeneration (AMD), hinting that the drugs might treat the common eye disease.
Read Article![](https://pbs.twimg.com/media/GSjAF9FX0AAHeLq.jpg)
![](https://pbs.twimg.com/media/GSZIYetWwAA5a0l.jpg)
Links:
![](https://pbs.twimg.com/media/GSDrIf3XoAADhz_.jpg)
Links:
![](/themes/custom/rheumnow_theme/assets/images/rheumnow_logo.png)
Dr. John Cush RheumNow ( View Tweet)
![](https://pbs.twimg.com/media/GRWnJH0bMAArq82.jpg)
![](https://pbs.twimg.com/media/GRU5YOxbAAEQDeg.jpg)
![](/themes/custom/rheumnow_theme/assets/images/rheumnow_logo.png)
Dr. John Cush RheumNow ( View Tweet)
![](https://pbs.twimg.com/media/GRQLJSdWoAAq9PI.jpg)
Future Big BiTEs (6.28.2024)
Dr. Jack Cush reviews the news, journal articles and regulatory announcements from the past week on RheumNow.com.
Read Article![](https://pbs.twimg.com/media/GRMhr42WcAA9nlH.jpg)
Links:
![](/themes/custom/rheumnow_theme/assets/images/rheumnow_logo.png)
Dr. John Cush RheumNow ( View Tweet)
JAK Inhibitors in Giant Cell Arteritis
Trials are underway evaluating the potential benefits of JAK inhibitors (JAKi) in giant cell arteritis (GCA) patients who are refractory to standards of care.
![](https://pbs.twimg.com/media/GRGhRcnXgAEpp2_.jpg)
![](/themes/custom/rheumnow_theme/assets/images/rheumnow_logo.png)
Dr. John Cush RheumNow ( View Tweet)
New indications for JAK inhibitors
There are several new positive RCTs for JAK inhibitors. Here is a summary of trials and new indications for JAKi in GCA, pediatrics, GI, dermatology and more.
Read Article![](https://pbs.twimg.com/media/GQ3dT_0WoAAmU4L.jpg)
![](https://pbs.twimg.com/media/GQsIFztWQAAv7kN.jpg)
EULAR 2024 Rheumatology Roundup (6.21.2024)
Drs. Artie Kavanaugh and Jack Cush discuss highlights from the EULAR 2024 meeting in Vienna
Read Article